A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably
Welcome back to Endpoints Weekly! Q1 earnings season is officially upon us. Max Gelman kicked off our coverage this week with a story about Johnson
President Donald Trump has picked Erica Schwartz, a former deputy surgeon general and Coast Guard veteran, to be the next CDC director — a likely
On Friday, Kailera Therapeutics raised a record-setting $625 million through an IPO on the Nasdaq. Founded with backing from Bain Capital Life Sciences, and a
The oncology field is buzzing after a landmark readout from Revolution Medicines, known colloquially as RevMed, showed that a targeted “pan-RAS” drug doubled the survival
In January, Revolution Medicines was rumored to have a $30 billion buyout offer on the table. Now, it doesn’t.
Also in January, Revolution didn’t have its Phase 3 pancreatic cancer results. Now, it does.
So …
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844